By transporting the fatty acids in your body to the mitochondria, which in turn, help burn the fat and convert it into energy
BMC Bioinf (2008) 9:559
The FDA-approved prescribing information states that tesamorelin is not indicated for weight-loss management because it has a weight-neutral effect. In the Phase 3 studies, total body weight changed very little even though the tesamorelin groups demonstrated reductions in: Visceral adipose tissue Waist circumference Trunk fat At the same time, modest increases in lean body mass were reported
This test is performed by lightly touching the tips of the first, third and fifth toes on each foot with a finger while the patient has their eyes closed, asking them to say yes if they feel the touch
doi: 10.1016/s0140-6736(66)92982-5 12 DruckerDJ
GLP-1 Companion Products Market Exclusions The GLP-1 receptor agonist drugs, such as Ozempic, Wegovy, and Mounjaro, are not included in the market because they represent a different therapeutic market (pharmaceutical therapeutics)